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Extranodal NK/T cell lymphoma(NKTCL), nasal type, occurring primarily in the prostate gland, is extremely rare. We
present a case of primarily prostatic NKTCL in a 59-year-old man suffering from dysuria. Histological examinations
revealed that diffused, large-sized, pleomorphic lymphocytes were arranged in an angiocentric distribution with large
areas of geographic necroses. Additionally, the prostatic glands were diffusely infiltrated by heteromorphous
lymphocytes forming lymphoepithelial lesions. The tumor cells were strongly expressed CD3ε, CD56, TIA-1, granzyme B
and EBV-encoded RNAs. And interestingly, the lymphoid cells were also strongly immunoreactive with CD30. A
rearrangement study showed T-cell receptor γ-chain gene rearrangement with monoclonal appearance. Though
postoperative combination of chemotherapy was given, the patient died four months later. Our observation and other
literatures indicate that extremely rare NKTCLs unusually express CD30. TCR gene rearrangement existed in some NKTCL,
suggesting that a subset of NKTCL may be a mixed NK/T-cell differentiation.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
9671878568932824.
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Extranodal NK/T cell lymphoma, nasal type (NKTCL)
is well known as an aggressive tumor that is characterized
by vascular damage and destruction, prominent geographic
necrosis, and associated with Epstein-Barr Virus (EBV).
The most common sites involve the upper aero-
digestive tract, with the nasal cavity being the proto-
typic site. The extranasal sites that NKTCL favors
include skin, gastrointestinal tract, and soft tissues
[1,2]. The NKTCL involving prostate is very rare [3].
Primary NKTCL has been not reported. Here, we re-
port a case of primary prostate NKTCL in a 59-year-old
man with CD30 positive expression and T-cell receptor
γ-chain gene rearrangement.* Correspondence: gaoxingcheng@163.com
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Clinical history
A 59-year-old man suffered from low fever for one month,
increased frequency of urination and dysuria for approxi-
mately a week. A computed tomography (CT) scan
revealed benign hyperplasia in the prostrate. Therefore, a
routine procedure of transurethral resection of prostate
was conducted. After the diagnosis of NKTCL, since
there was a great possibility of dissemination of other
sites’ NKTCL, the patient was referred to a whole body
positron emission tomography/computed tomography
(PET/CT) study to search for a potential primary
tumor, but no other abnormality was found. The lesion
was proved primarily occurred in prostate and just in
stageI. However, despite three courses of chemotherapy
were given, the patient died after four months with
wide dissemination of the tumor and rapidly deterio-
rated clinical symptoms.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Tissues were routinely fixed in 10% neutral buffered for-
malin and embedded in paraffin. Three micrometer-thick
sections were stained with hematoxylin and eosin. Im-
munohistochemical analyses were performed using the
ChemMate Envision/HRP Kit (Dako, Glostrup, Denmark).
Antibodies used in this study were CK, PSA, PSAP, P504S,
Vimentin, LCA, CD2, CD3ε, CD7, CD4, CD8, CD56,
CD30, ALK, TIA-1, granzyme-B, CD20, CD79a, CD138,
CD68, TdT, and ki-67. The antibodies were obtained from
Dako Cytomation (Carpinteria, CA) and Santa Cruz
Biotechnology (Santa Cruz, CA). Slides were dewaxed and
rehydrated routinely and then were treated with 10 mmol
citrate buffer (pH 6.0) in a microwave for antigen retrieval.
After incubation with diluted primary antibodies, slides
were treated with the ChemMate Envision/HRP Kit for 30
minutes at room temperature followed by development
with diaminobenzidine (DAB) for visualization.
In situ hybridization(ISH) was performed to detect
the Epstein-Barr virus encoded RNAs(EBERs) (DIG-AP,
A300 K.9901; PanPath, Netherlands). Detection process
was conducted according to manufacturer’s instructions.Figure 1 Histological examination. (a) Under low magnification, the tumor
magnification × 2). (b) The normal areas of prostate near the tumor (H&E staini
(H&E staining. original magnification × 20). (d) Glands are destroyed by tumor c
large with one to several prominent nucleoli, accompanying notable pathologFor cytogenetic analysis, the paraffin tissue DNA was
prepared with a tissue DNA extraction and purification
kit (Dneasy TM Tissue Kit, Qiagene, CA). T-cell recep-
tor rearrangement studies were performed. Two sets of
primers (tube A, 145–255 bp; tube B, 80-220bp) were
used to amplify the rearranged T-cell receptor (TCR)-γ
gene. A T cell lymphoma case with a known monoclonal
rearrangement was used as a positive control, a non-
lymphoid and hematopoietic tumor was used as a nega-
tive control, and a reaction without template DNA was
simultaneously run as a blank control. β-actin was amp-
lified as an internal control. The detection process was
conducted by methods described previously [4].
Pathological findings
The microscopic findings of the prostate revealed the
lesion was mainly infiltrated by intermediate- to large-
sized tumor cells with angiocentric and angiodestructive
growth pattern. The prostate gland damage was also
noted in the lesion. The tumor cells had irregular or
oval, hyperchromatic nuclei with one to several prominent
nucleoli, accompanying notable pathological mitosis anddiffuses with the large areas of necrosis (H&E staining, original
ng, original magnification × 4). (c) Tumor cells invade vessel wall seriously
ells (H&E staining. Original magnification × 20). (e, f) The tumor cells were
ical mitosis and apoptosis (H&E staining. Original magnification × 40).
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CD3ε, CD2, CD7, CD30, and CD56, perforin, TIA-1, rather
than CK, PSA, PSAP, P504S, Vimentin, CD79a, CD20,
CD4, CD8, and ALK (Figure 2). Ki67 was expressed
in nearly 90% of the tumor cells. EBERs signals were
detected diffusely in nuclei of the tumor cells (Figure 3).
Based on these results, the diagnosis of NKTCL with
CD30 expression was made. The rearrangement study
showed TCRG gene rearrangement with monoclonal
appearance (Figure 4).
Discussion
Besides of prostatic adenocarcinoma, there are a few
other types of neoplasms occurring in prostate which
are difficult to determine their primary origins, such as
prostatic squamous carcinoma [5]. Lymphomas of prostate,
either primary or secondary, are very rare. The types are
mainly consisted of B-cell lymphomas [6], including diffuse
large B-cell non-Hodgkin’s lymphoma (DLBL) [7], mucosa-
associated lymphoid tissue (MALT) lymphoma [8], andFigure 2 Immunohistochemical results. (a) Remnant gland epithelial cell
expression for tumor cells (SP, original magnification × 40). (c-e) Tumor cells
magnification × 40). (f) Tumor cells were positive for CD30 (SP, original magmantle cell lymphomas [9]. Only three cases of T-cell
lymphomas involving the prostate have been reported, but
none of them was primary [10,11]. According to the
criteria of Bostwick [3], primary prostatic lymphoma could
be diagnosed subject to the fulfillment of the following
conditions: primary symptoms are attributed to prostatic
enlargement; the disease is almost localized to the prostate;
and, NKTCL diagnosis does not include lymph nodes, liver,
spleen and other organs in 1-month. The symptoms of the
present case were only associated with prostatic hyperpla-
sia, and no tumor was detected in other organs through
the systemic PET-CT detection. In this manner, the
primary lymphoma of prostate was confirmed. The tumor
showed typical angiocentric and angiodestructive growth
patten, a typical immunophenotype expressing CD56,
CD3εand EBERs positive detection with ISH. Collect-
ively, the lesion was best recognized as NKTCL.
Cell morphology of NKTCL is comprehensive. Most
cases comprise middle cells mixed a few small- and
large-sized cells, and usually do not have nucleoli. Thes were positive for CK (SP, original magnification × 40). (b) LCA positive
were positive for CD3, CD2 and CD56, respectively (SP, original
nification × 40).
Figure 3 EBERs positive expression in tumor cells (→) (ISH,
original magnification × 40).
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cells containing several nucleoli. This tissue change may
indicate a poor prognosis [2]. Expression of CD30, an
important marker for anaplastic large-cell lymphomas,
in NKTCL is rare. One case of CD30+ NKTCL occur-
ring on skin was reported in 2008 [12]. In that case,
Strong CD30, CD3εand CD56 immunoreactivities were
noted in large atypical mononuclear cells. That patient
died within 8 months after the onset of skin lesions. In
another report, fine-needle aspiration of an large adrenal
mass and CSF cytology showed that large atypical cellsFigure 4 Multiplex PCR for T-cell receptor c-chain gene using 6%
polypropylene gel electrophoresis. Lane 1, DNA Marker. Lane 2
monoclonal(positive) control of tube A. Lane 3 polyclonal(negative)
control of tube A. Lane 4 blank control of tube A. Lane 5 monoclonal
T-cell receptor c-chain gene rearrangement in reproducible duplicate
of tube A. Lane 6 monoclonal(positive) control of tube B. Lane 7
polyclonal(negative) control of tube B. Lane 8 blank control of tube
B. Lane 9 monoclonal T-cell receptor c-chain gene rearrangement in
reproducible duplicate of tube B. Lane 10 β-actin.were positive for CD30, CD43, and CD56. The patient also
died a few days after the final diagnosis was achieved
though with high dose intravenous dexamethasone [13].
The case in the present study also revealed diffusely CD30
expression in large tumor cells. According to these cases, it
is speculated that NKTCL with large cells can express
CD30 and indicate a worse prognosis. But more cases are
necessary to prove it. In 2013, 17/40 cases CD30-positive
were found in a report of 73 cases at MD Anderson cancer
center, but had no further discussion about clinical
threatment and prognosis [14].
The rearrangement TCR genes is an important supple-
ment to the diagnosis of T-cell non-Hodgkin lymphoma.
TCR genes are clonally rearranged in most cases of PTCL,
NOS [15], while only a small proportion of NKTCLs show
clonal rearrangement [16,17]. However, some studies iden-
tified monoclonal TCRG gene rearrangement in a signifi-
cantly higher proportion of NKTCLs, suggesting a mixed
NK/T-cell differentiation in a subset of these tumors
[18,19]. The present case maybe belong in this subset.
Though with characteristic microscopic finds and
Immunohistochemical expression, differential diagnosis
is requisite before making a definite NKTCL, since pros-
tatic NKTCL is so rare. Poorly differentiated carcinoma
with diffuse tumor cells might represent some histo-
logical similarity with NKTCL, but it usually dose not
display angiocentric distribution with large geographic
necroses and lymphoepithelial lesions, and it often can
be found some heteromorphic glands. Immunohisto-
chemical results show expression of epithelial markers
such as CK, CK8/18 and PSA et al., rather than lympho-
cyte ones. Another rare tumor, prostatic stromal sarcoma,
is often showed pervasive small and medium-sized round
cells around the residual glands too [20]. It is suspiciously
derived from mesenchymal pluripotent stem cells in the
prostatic stroma and usually express CD10, CD34 and PR.
Conclusion
The case reported the possibility of NK/T cell lymphoma
primarily occurring in prostate. Compared with that of
other organs, the prognosis of the prostate disease is also
poor. The prognoses of those tumors mainly comprised
of big cells with CD30 positive expression are quite
unclear because of rare cases. The rearrangement of
TCR genes in NKTCL suggests a mixed NK/T-cell
differentiation in a subset of these tumors.
The medical/scientific value of this case report
It is well known the prognosis of prostatic adenocarcinoma
depend on its Gleason score, positive surgical margin
(PSM), perineural invasion (PNI), and abnormal expression
of some genes [21,22]. Nevertheless, these items are not fit
with other less happened neoplasms in prostate, such as
lymphoma. Though the primarily prostatic NKTCL is very
Jiang et al. Diagnostic Pathology 2013, 8:94 Page 5 of 5
http://www.diagnosticpathology.org/content/8/1/94rare, its accurate diagnosis is medically significant because
it is highly aggressive and its clinical prognosis is as poor
as ones in other sites. Its treatment is supposed to take
chemical therapy as done as NKTCL of other organs,
instead of traditional androgen deprivation therapy for
prostatic carcinomas. Usually, diagnosis procedure for
a primarily prostatic CD30 positive NKTCL includes
the following steps: 1. H&E staining reveals diffuse infil-
trated large-sized or anaplastic tumor cells with remarkable
apoptosis and angiocentric necrosis; 2. Immunohistochem-
ical results present the expression of LCA, CD2, CD3ε and
CD56, perforin, TIA-1, and CD30; 3. EBERs are detected
in tumor cells. 4. No tumor was detected in other organs.
Consent
To publish this case report and accompanying images,
written informed consent was obtained from the
patient’s family.
Abbreviation
NKTCL: Natural killer/T cell lymphoma.
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